SERPİL ERŞAN

SERPİL ERŞAN serves as Associate Professor in the Department of Medical Biochemistry under the Faculty of Medicine at Niğde Ömer Halisdemir University since 2018. She holds leadership roles including Head of Department (2022-present) and Quality Committee Member at Niğde University. Her academic journey includes prior positions as Lecturer at Cumhuriyet University's Advanced Technology Application Center (2017-2018) and Expert in Chemical Engineering (2000-2017).

• Doctorate in Biochemistry (2013-2016): Republic University, Thesis on oxidative stress in Crimean-Congo hemorrhagic fever
• Master's in Biochemistry (2001-2004): Sivas Republic University, Thesis on free radical metabolism in OCD
• Bachelor's in Chemistry (1990-1998): Republic University

Her research focuses on biochemical mechanisms in neurodegenerative and psychiatric disorders, particularly oxidative/nitrosative stress pathways in Alzheimer's disease, schizophrenia, and epilepsy. Recent work examines biomarker profiles including VEGF, TGF-β1, irisin, and arginine metabolites. She investigates diabetes complications through diabetic retinopathy studies and explores enzyme kinetics in conditions like COPD and ankylosing spondylitis. Her laboratory employs advanced techniques in protein analysis, gene expression, and metabolite quantification.

Analysis of her 15 most recent publications (2020-2024) reveals consistent themes: 73% focus on neurological/psychiatric conditions, 47% examine oxidative stress markers, and 33% investigate diabetes-related pathologies. Key methodological approaches include enzyme activity assays, biomarker correlation studies, and genetic polymorphism analysis. Her collaborative network spans 12+ institutions with frequent co-authorship among Turkish medical universities.

• Completed 12+ research projects including TUBITAK 3501 grants
• Investigated graphene's effect on lactate dehydragenase activity
• Studied epoxyeicosatrienoic acid metabolism in diabetic retinopathy
• Examined arginine metabolism in Alzheimer's disease

She supervises graduate research including SEYYID MEHMET BULUT's thesis on schizophrenia biomarkers. Her work integrates clinical biochemistry with molecular neuroscience, securing continuous funding from Higher Education Institutions. Current projects focus on epigenetic regulation in diabetic retinopathy and novel biomarkers for neurodegenerative diseases.